On Friday, Shares of Gilead Sciences, Inc. (NASDAQ:GILD), added 1.62% and closed at $79.12 in the last trading session. The last trading range of the stock ranges between $78.05 and $9.63. Gilead Sciences, Inc. (GILD) recently declared it has reached a partnership with the World Health Organization (WHO) to provide $20 million in funding and drug donations over five years to expand access to diagnostic services and treatment for visceral leishmaniasis (VL). As part of this collaboration, Gilead will donate 380,000 vials of AmBisome® (amphotericin B liposome for injection) to meet the needs of WHO to treat VL in key endemic countries, counting Bangladesh, Ethiopia, India, Nepal, South Sudan and Sudan.
VL, also known as kala-azar, is the world’s second-deadliest parasitic infectious disease and affects up to 300,000 people annually in resource-limited countries.
“This new partnershipcomes at the right time as we gear up to support endemic countries in the Eastern Africa sub-region and South-East Asia to eliminate visceral leishmaniasis as a public health problem by or before 2020,” said Dr. Ren Minghui, WHO Assistant Director-General for HIV/AIDS, Malaria and Neglected Tropical Diseases. “During the past five years, AmBisome, donated by Gilead, allowed many countries in the Region highly endemic for VL to implement WHO’s recommended first line treatment, benefitting thousands of people.”
WPX Energy Inc (NYSE:WPX), dropped -0.98% and closed at $13.19 in the last trading session. The last trading range of the stock ranges between $13.04 and $13.64. The company’s Market capitalization is $4.50 Billion with the total Outstanding Shares of 344.34 million. WPX Energy’s (WPX) board of directors has approved a quarterly dividend of $0.78125 per share to holders of the company’s 6.25 percent Series A Mandatory Convertible Preferred Stock. The dividend is payable on Oct. 31, 2016, to holders of record of the company’s preferred stock on Oct. 15, 2016.